ENTRY       D00438                      Drug
NAME        Nimodipine (USP/INN);
            Nimotop (TN);
            Nymalize (TN)
PRODUCT     NYMALIZE (Azurity Pharmaceuticals)
  GENERIC   NIMODIPINE (Ascend Laboratories)
            NIMODIPINE (BIONPHARMA)
            NIMODIPINE (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals)
            NIMODIPINE (McKesson Corporation dba SKY Packaging)
FORMULA     C21H26N2O7
EXACT_MASS  418.174
MOL_WEIGHT  418.4403
CLASS       Cardiovascular agent
             DG01575  Calcium channel blocker
              DG01496  Calcium channel L type blocker
             DG03231  Antihypertensive
              DG01928  Dihydropyridine calcium channel blocker
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C07267
            ATC code: C08CA06
            Product: D00438<US>
EFFICACY    Antihypertensive, Vasodilator, Calcium channel blocker
COMMENT     Dihydropyridine derivative
TARGET      CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]
  PATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway
            hsa04260(775+776+778+779)  Cardiac muscle contraction
            hsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes
            hsa04270(775+776+778+779)  Vascular smooth muscle contraction
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07036  Calcium channel blocking drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C08 CALCIUM CHANNEL BLOCKERS
               C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
                C08CA Dihydropyridine derivatives
                 C08CA06 Nimodipine
                  D00438  Nimodipine (USP/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Calcium Channel Blocking Agents, Dihydropyridines
               Nimodipine
                D00438  Nimodipine (USP/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01496  Calcium channel L type blocker
                D00438  Nimodipine
              DG03231  Antihypertensive
               DG01928  Dihydropyridine calcium channel blocker
                D00438  Nimodipine
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D00438  Nimodipine
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG01928  Dihydropyridine calcium channel blocker
               D00438  Nimodipine
              DG03231  Antihypertensive
               D00438  Nimodipine
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Calcium channels
                CACNA1-L
                 D00438  Nimodipine (USP/INN) &lt;US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00438
DBLINKS     CAS: 66085-59-4
            PubChem: 7847504
            ChEBI: 7575
            LigandBox: D00438
            NIKKAJI: J19.052G
ATOM        30
            1   C1y C    26.2694  -15.6084
            2   C8y C    26.2694  -17.0125
            3   C2y C    25.0525  -14.9064
            4   C2y C    27.4745  -14.9064
            5   C8x C    25.0525  -17.7086
            6   C8x C    27.4804  -17.7086
            7   C2y C    25.0525  -13.5141
            8   C7a C    23.8415  -15.6084
            9   C2y C    27.4745  -13.5141
            10  C7a C    28.6913  -15.6084
            11  C8y C    25.0525  -19.1127
            12  C8x C    27.4804  -19.1127
            13  N1x N    26.2694  -12.8120
            14  C1a C    23.8415  -12.8120
            15  O7a O    22.6305  -14.9064
            16  O6a O    23.8415  -17.0125
            17  C1a C    28.6913  -12.8120
            18  O7a O    29.9022  -14.9064
            19  O6a O    28.6913  -17.0066
            20  C8x C    26.2694  -19.8087
            21  N2b N    23.8475  -19.8147 #+
            22  C1b C    21.4195  -15.6084
            23  C1c C    31.1132  -15.6084
            24  O3a O    22.6305  -19.1127
            25  O3a O    23.8475  -21.2070 #-
            26  C1b C    20.2028  -14.9122
            27  C1a C    32.3242  -14.9064
            28  C1a C    31.0492  -17.0066
            29  O2a O    18.9918  -15.6142
            30  C1a C    17.7750  -14.9122
BOND        31
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 2
            6     3   7 2
            7     3   8 1
            8     4   9 2
            9     4  10 1
            10    5  11 2
            11    6  12 1
            12    7  13 1
            13    7  14 1
            14    8  15 1
            15    8  16 2
            16    9  17 1
            17   10  18 1
            18   10  19 2
            19   11  20 1
            20   11  21 1
            21   15  22 1
            22   18  23 1
            23   21  24 2
            24   21  25 1
            25   22  26 1
            26   23  27 1
            27   23  28 1
            28   26  29 1
            29   29  30 1
            30    9  13 1
            31   12  20 2
///
